prikaz prve stranice dokumenta Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)
  Download
PDF 503.85 KB
Scientific paper - Original scientific paper
Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)
Biomedicines, 10 (2022), 12; 3291. https://doi.org/10.3390/biomedicines10123291
Radić, Mislav; Novak, Srđan; Barešić, Marko; Hećimović, Ana; Perković, Dijana; Tekavec-Trkanjec, Jasna; Mayer, Miroslav; Prus, Višnja; Morović-Vergles, Jadranka; Marasović Krstulović, Daniela; Cerovec, Mislav; Bulat Kardum, Ljiljana; Samaržija, Miroslav; Anić, Branimir

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Radić, M., Novak, S., Barešić, M., Hećimović, A., Perković, D., Tekavec Trkanjec, J. ... Anić, B. (2022). Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study). Biomedicines, 10. (12), 3291. doi: 10.3390/biomedicines10123291

Radić, Mislav, et al. "Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)." Biomedicines, vol. 10, no. 12, 2022, pp. 3291. https://doi.org/10.3390/biomedicines10123291

Radić, Mislav, Srđan Novak, Marko Barešić, Ana Hećimović, Dijana Perković, Jasna Tekavec Trkanjec, Miroslav Mayer, et al. "Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)." Biomedicines 10, no. 12 (2022): 3291. https://doi.org/10.3390/biomedicines10123291

Radić, M., et al. (2022) 'Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)', Biomedicines, 10(12), pp. 3291. doi: 10.3390/biomedicines10123291

Radić M, Novak S, Barešić M, Hećimović A, Perković D, Tekavec Trkanjec J, and sur.. Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study). Biomedicines [Internet]. 2022 December 19 [cited 2024 November 08];10(12):3291. doi: 10.3390/biomedicines10123291

M. Radić, et al., "Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)", Biomedicines, vol. 10, no. 12, pp. 3291, December 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:108337. [Accessed: 08 November 2024]

Metadata
Title (english)Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian National-Based Study)
AuthorMislav Radić
AuthorSrđan Novak
AuthorMarko Barešić
AuthorAna Hećimović
AuthorDijana Perković
AuthorJasna Tekavec-Trkanjec
AuthorMiroslav Mayer
AuthorVišnja Prus
AuthorJadranka Morović-Vergles
AuthorDaniela Marasović Krstulović
AuthorMislav Cerovec
AuthorLjiljana Bulat Kardum
AuthorMiroslav Samaržija
AuthorBranimir Anić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
The aim of this study was to develop a Croatian Delphi-based expert consensus for screening interstitial lung disease (ILD) associated with connective tissue disease (CTD). A systematic literature review was conducted on risk factors for the development of ILD, prevalence and incidence of ILD, diagnostic and screening methods for ILD, and prognosis of ILD in idiopathic inflammatory myopathy (IIM), mixed connective tissue disease (MCTD), primary Sjögren’s syndrome (pSS), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc) were performed. Based on the evidence found, experts developed questionnaires for screening and monitoring ILD in each CTD, which were provided via an online survey. Following the electronic survey, two screening algorithms were developed based on the consensus opinions. The detection strategy for ILD included high-resolution computed tomography (HRCT) in addition to pulmonary function testing for IIM, MCTD, and SSc. and pulmonary function testing for newly diagnosed pSS, RA and SLE. However, in patients with identified risk factors for ILD HRCT, these tests should also be performed. A screening strategy for early identification of patients with various CTD-ILD was first developed by a multidisciplinary team of rheumatologists, pulmonologists, and radiologists to identify early CTD patients at risk of ILD, a severe extra-articular manifestation of CTD.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleBiomedicines
Numberingvol. 10, no. 12, p. 3291, 3291
e-ISSN2227-9059
DOIhttps://doi.org/10.3390/biomedicines10123291
URN:NBNurn:nbn:hr:184:108337
Publication2022-12-19
Document URLhttps://www.mdpi.com/2227-9059/10/12/3291
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2023-01-31 09:59:58